Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin Added to Insulin in Haemodialyzed Patients With Type 2 Diabetes
NCT02176681Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2014
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vildagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Mean glucose value of Continuous Glucose Monitoring (CGM) at day 3. Started Jun 2014; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02176681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176681.